| Product Code: ETC11380361 | Publication Date: Apr 2025 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The anti-rheumatics import market in Brunei saw a significant increase in concentration in 2024, with a high Herfindahl-Hirschman Index (HHI). Despite a negative Compound Annual Growth Rate (CAGR) from 2020 to 2024, the growth rate improved slightly from 2023 to 2024. Key exporting countries like Malaysia, Singapore, Ireland, USA, and Australia continue to dominate the market, showcasing a strong presence in the Bruneian pharmaceutical sector. The market dynamics suggest a competitive landscape with potential opportunities for market players to explore in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Anti Rheumatics Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Anti Rheumatics Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Anti Rheumatics Market - Industry Life Cycle |
3.4 Brunei Anti Rheumatics Market - Porter's Five Forces |
3.5 Brunei Anti Rheumatics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Brunei Anti Rheumatics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Brunei Anti Rheumatics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Brunei Anti Rheumatics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Anti Rheumatics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Brunei Anti Rheumatics Market Trends |
6 Brunei Anti Rheumatics Market, By Types |
6.1 Brunei Anti Rheumatics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Anti Rheumatics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Brunei Anti Rheumatics Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Brunei Anti Rheumatics Market Revenues & Volume, By DMARDs, 2021 - 2031F |
6.1.5 Brunei Anti Rheumatics Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.2 Brunei Anti Rheumatics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Brunei Anti Rheumatics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Brunei Anti Rheumatics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Brunei Anti Rheumatics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Brunei Anti Rheumatics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Brunei Anti Rheumatics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Brunei Anti Rheumatics Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Brunei Anti Rheumatics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Brunei Anti Rheumatics Market Revenues & Volume, By Retail, 2021 - 2031F |
6.4.3 Brunei Anti Rheumatics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4.4 Brunei Anti Rheumatics Market Revenues & Volume, By Online, 2021 - 2031F |
7 Brunei Anti Rheumatics Market Import-Export Trade Statistics |
7.1 Brunei Anti Rheumatics Market Export to Major Countries |
7.2 Brunei Anti Rheumatics Market Imports from Major Countries |
8 Brunei Anti Rheumatics Market Key Performance Indicators |
9 Brunei Anti Rheumatics Market - Opportunity Assessment |
9.1 Brunei Anti Rheumatics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Brunei Anti Rheumatics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Brunei Anti Rheumatics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Brunei Anti Rheumatics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Anti Rheumatics Market - Competitive Landscape |
10.1 Brunei Anti Rheumatics Market Revenue Share, By Companies, 2024 |
10.2 Brunei Anti Rheumatics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |